- My Library
- 2023 Issues
- Issue 62
- Pay attention to the evidence: in…
Pay attention to the evidence: in the longer term, intraarticular corticosteroid injections offer only harm for knee osteoarthritis
Key Points
- There is no evidence that intra-articular corticosteroid injections provide any long-term benefits for treatment of knee osteoarthritis.
All key points available for members only
BACKGROUND & OBJECTIVE
Intra-articular corticosteroid injections (IACIs) are a common treatment for knee osteoarthritis, but there is evidence that their benefits are limited to the short term, and that they cause harm in the long term.
This paper was a commentary reviewing some of the relevant evidence and arguing that medical care providers should discontinue use of IACIs as a treatment for knee osteoarthritis.
Intra-articular corticosteroid injections are a common treatment for knee osteoarthritis, but there is evidence that their benefits are limited to the short term.
Intra-articular corticosteroid injections might cause long term harm through cartilage degeneration, and/or increasing the probability of surgery and its associated risks, such as infection.
METHODS
This paper reviewed some systematic reviews, RCTs and meta-analyses concerning the medium and long-term effects of IACI treatment compared to placebo and alternative treatments. It also rebuts arguments from experts who recommend the continued use of IACIs for treatment of
to unlock full access to this review and 1109 more